Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R. White

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.
Gastroenterology|August 24, 2020
Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal InflammationAmrita Banerjee, Charles A Herring, Bob Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stabilityYujie Zhao, Jarushka Naidoo, Michael Conroy, et al.
Cancer Discovery|February 26, 2021
Bacterial-Driven Inflammation and Mutant <i>BRAF</i> Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint TherapyChristina E DeStefano Shields, James R White, Liam Chung, et al.
Cancer Research|September 8, 2022
Genomic Landscapes and Hallmarks of Mutant RAS in Human CancersRobert B Scharpf, Archana Balan, Biagio Ricciuti, et al.
The Journal of Clinical Investigation|March 12, 2019
Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenicSarah Tomkovich, Christine M Dejea, Kathryn Winglee, et al.
Cell Reports. Medicine|December 9, 2020
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in MelanomaValsamo Anagnostou, Daniel C Bruhm, Noushin Niknafs, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapyMichael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, et al.
Cancers|November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and ImmunotherapyFyza Y Shaikh, Seoho Lee, James R White, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.
Gastroenterology|August 24, 2020
Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal InflammationAmrita Banerjee, Charles A Herring, Bob Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stabilityYujie Zhao, Jarushka Naidoo, Michael Conroy, et al.
Cancer Discovery|February 26, 2021
Bacterial-Driven Inflammation and Mutant <i>BRAF</i> Expression Combine to Promote Murine Colon Tumorigenesis That Is Sensitive to Immune Checkpoint TherapyChristina E DeStefano Shields, James R White, Liam Chung, et al.
Cancer Research|September 8, 2022
Genomic Landscapes and Hallmarks of Mutant RAS in Human CancersRobert B Scharpf, Archana Balan, Biagio Ricciuti, et al.
The Journal of Clinical Investigation|March 12, 2019
Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenicSarah Tomkovich, Christine M Dejea, Kathryn Winglee, et al.
Cell Reports. Medicine|December 9, 2020
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in MelanomaValsamo Anagnostou, Daniel C Bruhm, Noushin Niknafs, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapyMichael Hwang, Jenna Vanliere Canzoniero, Samuel Rosner, et al.
Cancers|November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and ImmunotherapyFyza Y Shaikh, Seoho Lee, James R White, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Pageof 14